The unchanged US$9.88 fair value estimate for LifeMD keeps the core price target steady, even as model inputs see only marginal tweaks. That stability lines up with recent analyst debate around Q4 ...

GLP Diet app review pieces are popping up at the same moment interest in Ozempic and other GLP-1 drugs is beginning to cool, ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

A weight management doctor and exercise physiologist share three strength exercises to prevent GLP-1 muscle loss.

Core Progression Elite Personal Training ("Core Progression") and Vitelize Health ("Vitelize") have launched a coordinated GLP-1 weight-loss model that places independent, physician-directed clinics ...

Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market. And in recent years, their popularity has soared due to ...

The weight loss drugs are impacting the restaurant behavior of consumers in different ways, and sometimes it divides along ...

A major meta-analysis of 11 cardiovascular outcome trials has found that GLP‑1 receptor agonists, including semaglutide, reduce the risk of major adverse cardiovascular events by about 13% in ...

Core Balance Health and Wellness expands access to weight loss care through transparent GLP-1 treatment options and flexible ...

Slimpic has emerged in 2026 as one of the most discussed natural weight management formulas in the prebiotic and probiotic ...

Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...